Ruben King Shaw - Jan 29, 2019 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)

Role
Director
Signature
/s/ Ruben King-Shaw Jr.
Stock symbol
AVRW
Transactions as of
Jan 29, 2019
Transactions value $
$0
Form type
4
Date filed
5/27/2021, 07:41 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRW Stock Option Award $0 +100K $0.00 100K Jan 29, 2019 Common Stock 100K $3.40 Direct F1
transaction AVRW Restricted Stock Unit Award $0 +61.7K $0.00 61.7K Sep 23, 2020 Common Stock 61.7K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable on the basis determined by the equity incentive plan with 12.5% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100% date. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
F2 The reporting person received restricted stock units under the equity incentive plan. Vesting occurs within a one-year term or until the next annual meeting of shareholders. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. This late filing is due to an inadvertent administrative error and not any error of the reporting person.